PubMed (RefSeq) for id: 2217309224

Year	Number of Results
1998	2
1999	1
2000	10
2001	6
2002	11
2003	6
2004	18
2005	15
2006	11
2007	8
2008	16
2009	8
2010	11
2011	7
2012	10
2013	17
2014	11
2015	8
2016	11
2017	8
2018	10
2019	3
2020	3
2021	10
2022	11
2023	3
2024	2

1

Interaction network of human early embryonic transcription factors.

Gawriyski L, Tan Z, Liu X, Chowdhury I, Malaymar Pinar D, Zhang Q, Weltner J, Jouhilahti EM, Wei GH, Kere J, Varjosalo M. Gawriyski L, et al. EMBO Rep. 2024 Mar;25(3):1589-1622. doi: 10.1038/s44319-024-00074-0. Epub 2024 Jan 31. EMBO Rep. 2024. PMID: 38297188 Free PMC article.

2

Histone Trimethylations and HDAC5 Regulate Spheroid Subpopulation and Differentiation Signaling of Human Adipose-Derived Stem Cells.

Chang MM, Hong YK, Hsu CK, Harn HI, Huang BM, Liu YH, Lu FI, Hsueh YY, Lin SP, Wu CC. Chang MM, et al. Stem Cells Transl Med. 2024 Mar 15;13(3):293-308. doi: 10.1093/stcltm/szad090. Stem Cells Transl Med. 2024. PMID: 38173411 Free PMC article.

3

NFYB increases chemosensitivity in glioblastoma by promoting HDAC5-mediated transcriptional inhibition of SHMT2.

Zhang Y, Huang H, Liu P, Xie Y. Zhang Y, et al. J Neuropathol Exp Neurol. 2023 Oct 20;82(11):911-920. doi: 10.1093/jnen/nlad073. J Neuropathol Exp Neurol. 2023. PMID: 37742129

4

AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis.

Sun Z, Jiang Q, Gao B, Zhang X, Bu L, Wang L, Lin Y, Xie W, Li J, Guo J. Sun Z, et al. Cancer Res. 2023 Apr 14;83(8):1264-1279. doi: 10.1158/0008-5472.CAN-22-3407. Cancer Res. 2023. PMID: 36806887

5

HDAC5-mediated Smad7 silencing through MEF2A is critical for fibroblast activation and hypertrophic scar formation.

Gao Y, Liu Y, Zheng D, Ho C, Wen D, Sun J, Huang L, Liu Y, Li Q, Zhang Y. Gao Y, et al. Int J Biol Sci. 2022 Sep 11;18(15):5724-5739. doi: 10.7150/ijbs.76140. eCollection 2022. Int J Biol Sci. 2022. PMID: 36263180 Free PMC article.

6

METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.

Zhang Y, Qiu JG, Jia XY, Ke Y, Zhang MK, Stieg D, Liu WJ, Liu LZ, Wang L, Jiang BH. Zhang Y, et al. Cancer Lett. 2023 Jan 28;553:215971. doi: 10.1016/j.canlet.2022.215971. Epub 2022 Oct 17. Cancer Lett. 2023. PMID: 36257380

7

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patients.

Chervy M, Sivignon A, Dambrine F, Buisson A, Sauvanet P, Godfraind C, Allez M, Le Bourhis L, The Remind Group, Barnich N, Denizot J. Chervy M, et al. Gut Microbes. 2022 Jan-Dec;14(1):2127444. doi: 10.1080/19490976.2022.2127444. Gut Microbes. 2022. PMID: 36175163 Free PMC article.

8

HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer.

Pan P, Qin G, Wang B, Yu H, Chen J, Liu J, Bing K, Shen J, Ren D, Zhao Y, Xia W, Li H, Wu H, Zhou Y. Pan P, et al. Cancer Res. 2022 Dec 16;82(24):4542-4554. doi: 10.1158/0008-5472.CAN-21-4362. Cancer Res. 2022. PMID: 36102738 Free PMC article.

9

HDAC5 inactivates CYR61-regulated CD31/mTOR axis to prevent the occurrence of preeclampsia.

Jiang P, Ying X, Li Z, Jiang R, Zhou J, Zhang M, Yang X, Zhu X. Jiang P, et al. Cell Tissue Res. 2022 Nov;390(2):281-292. doi: 10.1007/s00441-022-03652-7. Epub 2022 Jul 28. Cell Tissue Res. 2022. PMID: 35900603

10

HDAC5, negatively regulated by miR-148a-3p, promotes colon cancer cell migration.

OuYang C, Shu G, Liu J, Deng S, Lu P, Li Y, Gan Y, Xie B, Liu J, Yin G. OuYang C, et al. Cancer Sci. 2022 Aug;113(8):2560-2574. doi: 10.1111/cas.15399. Epub 2022 Jun 5. Cancer Sci. 2022. PMID: 35574707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

216 results

Results by year